Dakeishi Miwako, Shioya Takanobu, Wada Yasuhiko, Shindo Tsutomu, Otaka Kousei, Manabe Motomu, Nozaki Jun-Ichi, Inoue Sumiko, Koizumi Akio
Department of Hygiene, Akita University School of Medicine, Akita, Japan.
Hum Mutat. 2002 Feb;19(2):140-8. doi: 10.1002/humu.10026.
Hereditary hemorrhagic telangiectasia (HHT or Rendu-Osler-Weber syndrome) is an autosomal dominant disorder characterized by aberrant vascular development. We report here a genetic epidemiologic study in a county, A, in the Akita prefecture (population 1.2 million) located in northern Japan. Nine HHT patients who had been referred to tertiary-care hospitals were located in and near the study county. A total of 137 pedigree members were traced of which 81 were alive and 32 were affected by HHT. Complications associated with cerebral or pulmonary arteriovenous malformations were proven in six out of seven families. Linkage analysis in two large families revealed a weak yet suggestive linkage to the HHT1 locus (encoding endoglin; ENG). Three novel mutations were found in four families, all of which led to a frameshift: a G to C transversion at the splicing donor site of intron 3 (Inv3+1 G>C) in one family, one base pair insertion (A) at nucleotide 828 (exon 7) of the endoglin cDNA in two large families (c.828-829 ins A), and a four base pair deletion (AAAG) beginning with nucleotide 1120 (exon 8) of the endoglin cDNA (c.1120-1123 delAAAG) in one family. The insertion of A in exon 11 (c.1470-1471 insA) mutation found in one family has also been reported in a European family. No endoglin gene mutations were found in two families. The population prevalence of HHT in the county was estimated to be 1:8,000 approximately 1:5,000, roughly comparable with those reported in European and U.S. populations, which is contradictory to the traditional view that HHT is rare among Asians. We recommend that families with HHT be screened for gene mutations in order that high-risk individuals receive early diagnosis and treatment initiation that will substantially alter their clinical course and prognosis.
遗传性出血性毛细血管扩张症(HHT或Rendu - Osler - Weber综合征)是一种常染色体显性疾病,其特征为血管发育异常。我们在此报告一项在日本北部秋田县A郡(人口120万)开展的遗传流行病学研究。九名曾被转诊至三级医疗机构的HHT患者位于研究郡及其附近地区。共追踪到137名系谱成员,其中81人在世,32人受HHT影响。七个家庭中的六个家庭证实存在与脑或肺动静脉畸形相关的并发症。对两个大家庭进行的连锁分析显示与HHT1基因座(编码内皮糖蛋白;ENG)存在微弱但有提示性的连锁关系。在四个家庭中发现了三个新突变,均导致移码突变:一个家庭在内含子3的剪接供体位点发生G到C的颠换(Inv3 + 1 G>C),两个大家庭在内皮糖蛋白cDNA的核苷酸828(外显子7)处有一个碱基对插入(A)(c.828 - 829 ins A),一个家庭在内皮糖蛋白cDNA的核苷酸1120(外显子8)处开始有一个四碱基对缺失(AAAG)(c.1120 - 1123 delAAAG)。在一个家庭中发现的外显子11插入A(c.1470 - 1471 insA)突变在一个欧洲家庭中也有报道。在两个家庭中未发现内皮糖蛋白基因突变。该郡HHT的人群患病率估计约为1:8000至1:5000,与欧洲和美国人群的报告患病率大致相当,这与传统认为HHT在亚洲人中罕见的观点相矛盾。我们建议对HHT家庭进行基因突变筛查,以便高危个体能够尽早得到诊断并开始治疗,这将显著改变他们的临床病程和预后。